<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beryozkin A</submitter><funding>The German Research Council/DFG in the frame of the SPP SPP2127</funding><funding>Israeli Ministry of Health</funding><funding>The German Research Council/DFG in the frame of the SPP SPP2127 -</funding><pagination>3541</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8998412</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(7)</volume><pubmed_abstract>Ataluren and Gentamicin are translational readthrough drugs (TRIDs) that induce premature termination codon (PTC) readthrough, resulting in the production of full-length proteins that usually harbor a single missense substitution. FAM161A is a ciliary protein which is expressed in photoreceptors, and pathogenic variants in this gene cause retinitis pigmentosa (RP). Applying TRIDs on fibroblasts from RP patients due to PTC in the &lt;i>FAM161A&lt;/i> (p.Arg523*) gene may uncover whether TRIDs can restore expression, localization and function of this protein. Fibroblasts from six patients and five age-matched controls were starved prior to treatment with ataluren or gentamicin, and later FAM161A expression, ciliogenesis and cilia length were analyzed. In contrast to control cells, fibroblasts of p</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Translational Read-Through Drugs (TRIDs) Are Able to Restore Protein Expression and Ciliogenesis in Fibroblasts of Patients with Retinitis Pigmentosa Caused by a Premature Termination Codon in &lt;i>FAM161A&lt;/i>.</pubmed_title><pmcid>PMC8998412</pmcid><funding_grant_id>FAUN</funding_grant_id><funding_grant_id>USHER2020</funding_grant_id><funding_grant_id>3-14995</funding_grant_id><funding_grant_id>NA1398/1-1</funding_grant_id><pubmed_authors>Beryozkin A</pubmed_authors><pubmed_authors>Sharon D</pubmed_authors><pubmed_authors>Gopalakrishnan P</pubmed_authors><pubmed_authors>Nagel-Wolfrum K</pubmed_authors><pubmed_authors>Khateb S</pubmed_authors><pubmed_authors>Samanta A</pubmed_authors><pubmed_authors>Banin E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Translational Read-Through Drugs (TRIDs) Are Able to Restore Protein Expression and Ciliogenesis in Fibroblasts of Patients with Retinitis Pigmentosa Caused by a Premature Termination Codon in &lt;i>FAM161A&lt;/i>.</name><description>Ataluren and Gentamicin are translational readthrough drugs (TRIDs) that induce premature termination codon (PTC) readthrough, resulting in the production of full-length proteins that usually harbor a single missense substitution. FAM161A is a ciliary protein which is expressed in photoreceptors, and pathogenic variants in this gene cause retinitis pigmentosa (RP). Applying TRIDs on fibroblasts from RP patients due to PTC in the &lt;i>FAM161A&lt;/i> (p.Arg523*) gene may uncover whether TRIDs can restore expression, localization and function of this protein. Fibroblasts from six patients and five age-matched controls were starved prior to treatment with ataluren or gentamicin, and later FAM161A expression, ciliogenesis and cilia length were analyzed. In contrast to control cells, fibroblasts of p</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-06-19T03:12:34.84Z</modification><creation>2024-11-10T08:49:44.913Z</creation></dates><accession>S-EPMC8998412</accession><cross_references><pubmed>35408898</pubmed><doi>10.3390/ijms23073541</doi></cross_references></HashMap>